ahlam1399
07-03-2015, 09:11 PM
Hospira wins French biosimilar drug tender at 45 percent discount
PARIS (Reuters) - A major French hospital group has chosen a cheap copycat version of a top-selling drug for treating its patients with rheumatoid arthritis and Crohn's disease in a victory for a new type of medicine k**wn as biosimilars.***
http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/47d01bb6/sc/26/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=Pl6oPwMn20s:JpY0EeWOuBQ:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=Pl6oPwMn20s:JpY0EeWOuBQ:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=Pl6oPwMn20s:JpY0EeWOuBQ:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=Pl6oPwMn20s:JpY0EeWOuBQ:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=Pl6oPwMn20s:JpY0EeWOuBQ:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/Pl6oPwMn20s
PARIS (Reuters) - A major French hospital group has chosen a cheap copycat version of a top-selling drug for treating its patients with rheumatoid arthritis and Crohn's disease in a victory for a new type of medicine k**wn as biosimilars.***
http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/47d01bb6/sc/26/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=Pl6oPwMn20s:JpY0EeWOuBQ:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=Pl6oPwMn20s:JpY0EeWOuBQ:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=Pl6oPwMn20s:JpY0EeWOuBQ:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=Pl6oPwMn20s:JpY0EeWOuBQ:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=Pl6oPwMn20s:JpY0EeWOuBQ:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/Pl6oPwMn20s